Form 4: Shattuck Labs Chief Medical Officer Sells Shares to Cover Tax Obligations

Arundathy N. Pandite, Chief Medical Officer of Shattuck Labs, sold 6,884 shares of common stock to cover tax obligations.

Summary

• A Form 4 filing indicates that Arundathy N. Pandite, the Chief Medical Officer of Shattuck Labs, sold 6,884 shares of common stock on January 10, 2025.
• The shares were sold at a price of $1.19 per share.
• Following the transaction, Ms. Pandite directly owns 209,476 shares of Shattuck Labs common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock sale by an officer for tax purposes, which is neither positive nor negative for the company's outlook.

Industry Context

Form 4 filings are a standard part of regulatory compliance for company insiders and are routinely monitored by investors to understand insider trading activity.

Comparison to Industry Standards

• Form 4 filings are a standard practice for all publicly traded companies in the US, and the information provided is consistent with what is expected in such filings.
• The sale of shares by a company officer to cover tax obligations is a common occurrence and does not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company officer may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial health.

Key Dates

Keywords

Shattuck Labs, STTK, Form 4, insider trading, stock sale, Arundathy N. Pandite, Chief Medical Officer, equity securities